• No results found

[PDF] Top 20 High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non- small-cell lung cancer

Has 10000 "High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non- small-cell lung cancer" found on our website. Below are the top 20 most common "High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non- small-cell lung cancer".

High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non- small-cell lung cancer

High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non- small-cell lung cancer

... of HTRA3 (long and short) have unique structural ...of HTRA3-L nor the seven-residue C-terminal sequence of HTRA3-S was essential for their protease ...the HTRA3 trimer, and performed an ... See full document

10

Postoperative survival of EGFR TKI targeted therapy in non small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study

Postoperative survival of EGFR TKI targeted therapy in non small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study

... 2094 postoperative non-small cell lung cancer (NSCLC) patients with EGFR gene detection were collected in the Department of Pathology in the Cancer Hospital Chinese ... See full document

8

Original Article DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients

Original Article DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients

... in non-small cell lung cancer patients is largely unknown until ...corresponding non-cancerous lung tissues (P<0.001). Positive DDIAS expression ... See full document

10

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy

... NSCLC patients receiving radiotherapy ...study. Patients receiving a BED of radia- tion no less than 78 Gy had a longer LRFS than did those receiving a BED less than 78 ...to patients with local ... See full document

8

Overall  survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients

... taxel. Patients who received pemetrexed maintenance therapy after induction by the same agent were included in the ...study. Patients’ age, performance status, and underlying disease were also taken into ... See full document

8

A potential signature of eight long non coding RNAs predicts survival in patients with non small cell lung cancer

A potential signature of eight long non coding RNAs predicts survival in patients with non small cell lung cancer

... for lung cancer at the protein-coding genes and miRNAs levels [43, ...characterized cancer subtype-associated lncRNAs in breast cancer and lung cancer, proposing a novel clinical ... See full document

13

High p Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non small cell lung cancer

High p Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non small cell lung cancer

... All slides were evaluated independently by two experi- enced pathologists (Li F and Zhang Y). Ten high-power fields were selected randomly for each slide. The expres- sion levels of each marker in cancer ... See full document

6

&lt;p&gt;Radiotherapy for patients with completely resected pathologic IIIA(N2) non&amp;ndash;small-cell lung cancer: a retrospective analysis&lt;/p&gt;

<p>Radiotherapy for patients with completely resected pathologic IIIA(N2) non&ndash;small-cell lung cancer: a retrospective analysis</p>

... treatment, lung cancer remains the leading cause of cancer- related deaths in ...of non-small-cell lung cancer (NSCLC) patients are diagnosed at a locally ... See full document

8

Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer

Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer

... with recurrence of lung cancer. In cancer pa- tients, oxidative stress can be caused by various tumor pro- gression mechanisms, such as malignant conversion; tumor cell survival, ... See full document

7

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

... ty-five patients were treated with afatinib, whereas 28 patients were treated with ...All patients had documented EGFR mutations including exon 18 and exon 19 ...More patients in the afatinib ... See full document

10

Original Article FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer

Original Article FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer

... Lung cancer is the most commonly diagnosed cancer as well as the leading cause of cancer- related mortality worldwide, with over 1 million deaths each year [1], and although significant ... See full document

15

Original Article Expression of ATM, CHK2 and BRCA1 predicts the clinical outcome of non-small cell lung cancer in patients receiving platinum-based chemotherapy

Original Article Expression of ATM, CHK2 and BRCA1 predicts the clinical outcome of non-small cell lung cancer in patients receiving platinum-based chemotherapy

... higher expression of ATM in younger patients can result in an enhanced radiosensitivity and therefore better survival ...reflected survival time in NSCLC patients ...protein ... See full document

9

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer

... 3,923 patients were included based on inclusion ...alone, postoperative chemotherapy significantly improved DFS and OS with HR of ...significant survival benefits, but the latter did not improve DFS ... See full document

11

&lt;p&gt;Clinical Features and Prognostic Factor of Thoracic Postoperative Oligo-Recurrence of Non-Small-Cell Lung Cancer&lt;/p&gt;

<p>Clinical Features and Prognostic Factor of Thoracic Postoperative Oligo-Recurrence of Non-Small-Cell Lung Cancer</p>

... registered patients is limited to 56 ...after lung cancer surgery, and most of them are small sample studies, mostly due to the proportion of patients with oligo- recurrence ... See full document

7

Cetuximab and biomarkers in non-small-cell lung carcinoma

Cetuximab and biomarkers in non-small-cell lung carcinoma

... Abstract: Cancer progression is a highly complex process that is driven by a constellation of deregulated signaling pathways and key molecular ...In non-small-cell lung cancer ... See full document

11

Original Article Prognostic factors for patients with postoperative metastasis from non-small-cell lung cancer

Original Article Prognostic factors for patients with postoperative metastasis from non-small-cell lung cancer

... for non-small-cell lung cancer (NSCLC) patients with postoperative metastasis to different ...NSCLC patients who underwent complete resection and had recurrent ... See full document

8

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer

... and cell proliferation. The authors examined 80 samples from the Cancer Genome Atlas and demonstrated that breast cancer patients with high SRC3 and PFKFB4 mRNA expression have ... See full document

8

Resectable left lower lobe non–small cell lung cancer with lymph node metastasis is related to unfavorable outcomes

Resectable left lower lobe non–small cell lung cancer with lymph node metastasis is related to unfavorable outcomes

... as non-upper and upper, right- and left-sided, and left lower lobe (LLL) and non- LLL tumor, were ...the survival of patients with resect- able NSCLC [15, ...NSCLC patients who had ... See full document

8

Original Article The association between SLFN5 expression and the prognosis of non-small cell lung cancer

Original Article The association between SLFN5 expression and the prognosis of non-small cell lung cancer

... adjacent non-can- cerous tissue specimens submitted by Outdo Biotech ...of patients had a pathological diagnosis of lung adenocar- cinoma without lung transplantation, radiation therapy, ... See full document

8

The roles of metallothioneins in carcinogenesis

The roles of metallothioneins in carcinogenesis

... ovarian cancer [22, 118], breast cancer [119, 120], small cell lung cancer [121], non-small cell lung cancer [122], renal cell carcinoma ... See full document

20

Show all 10000 documents...